Hello! This week’s ETF Wrap digs into the jump in biotech funds, as well as…
AMGN
-
-
STOCK MARKET
Amazon’s stock could lose to Walgreens’ this year if the Dow jinx holds
by userby userThe keepers of the Dow Jones Industrial Average have been very good at making sure…
-
STOCK MARKET
Amgen’s quarterly results top expectations despite Enbrel sales decline
by userby userAmgen Inc. on Tuesday reported fourth-quarter profits and sales that topped analysts’ expectations even as revenues…
-
Investors can count on the Dow Jones Industrial Average changing its members next month, for…
-
STOCK MARKET
Nvidia dives deeper into AI drug development with Amgen, Recursion partnerships
by userby userNvidia Corp. NVDA, +4.88% is doubling down on artificial-intelligence-powered drug discovery and development, announcing expanded…
-
STOCK MARKET
Amgen gets FDA approval for its inflammatory diseases treatment Wezlana
by userby userAmgen AMGN, -2.85% has received approval from the U.S. Food and Drug Administration for Wezlana,…
-
STOCK MARKET
Amgen’s stock hit by expectations its obesity pipeline is facing a longer wait
by userby userAmgen Inc.’s stock fell 3.3% Tuesday to put it on track for its biggest one-day…
-
STOCK MARKET
Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations
by userby userMedicare on Tuesday announced the first 10 drugs to be selected for a price-negotiation program…
-
STOCK MARKET
Stock buybacks spur wealth inequality and stifle innovation. Should they be banned?
by userby userStock buybacks have become a major source of wealth inequality and have stifled innovation in…
-
The Rule of 40 is a shorthand way for venture-capital investors to evaluate companies. These…